Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.
Article Details
- CitationCopy to clipboard
Caras IW, Davitz MA, Rhee L, Weddell G, Martin DW Jr, Nussenzweig V
Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins.
Nature. 1987 Feb 5-11;325(6104):545-9.
- PubMed ID
- 2433596 [ View in PubMed]
- Abstract
Decay-accelerating factor (DAF), a glycoprotein that is anchored to the cell membrane by phosphatidylinositol, binds activated complement fragments C3b and C4b, thereby inhibiting amplification of the complement cascade on host cell membranes. Here, we report the molecular cloning of human DAF from HeLa cells. Analysis of DAF complementary DNAs revealed two classes of DAF messenger RNA, one apparently derived from the other by a splicing event that causes a coding frameshift near the C terminus. The apparent 'intron' sequence contains an Alu family member and encodes contiguous protein sequence. Two DAF proteins are therefore possible, having divergent C-terminal domains which differ in their hydrophobicity. Both mRNAs are found on polysomes, suggesting that both are translated. We propose that the major (90%) spliced DAF mRNA encodes membrane-bound DAF whereas the minor (10%) unspliced DAF mRNA may encode secreted DAF and we present expression data supporting this. The deduced DAF sequence contains four repeating units homologous to a consensus repeat found in a recently described family of complement proteins.